Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0I0NU
|
|||
| Former ID |
DIB009392
|
|||
| Drug Name |
NKP-2235
|
|||
| Synonyms |
AP-002
Click to Show/Hide
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199] | Phase 1/2 | [1] | |
| Company |
Niiki Pharma Inc
|
|||
| Structure |
 |
Download2D MOL
|
||
| Formula |
C27H18GaN3O3
|
|||
| Canonical SMILES |
C1=CC2=C(C(=C1)[O-])N=CC=C2.C1=CC2=C(C(=C1)[O-])N=CC=C2.C1=CC2=C(C(=C1)[O-])N=CC=C2.[Ga+3]
|
|||
| InChI |
1S/3C9H7NO.Ga/c3*11-8-5-1-3-7-4-2-6-10-9(7)8;/h3*1-6,11H;/q;;;+3/p-3
|
|||
| InChIKey |
KWQNQSDKCINQQP-UHFFFAOYSA-K
|
|||
| CAS Number |
CAS 14642-34-3
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04143789) Evaluation of AP-002 in Patients With Solid Tumors. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.